NCT05898399
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05898399
Title Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
Acronym POLKA
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Artios Pharma Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
South Texas Accelerated Research Therapeutics (START) - Midwest ACTIVE_NOT_RECRUITING Grand Rapids Michigan 49546 United States Details
Memorial Sloan-Kettering Cancer Center (MSKCC) ACTIVE_NOT_RECRUITING New York New York 10065-6800 United States Details
Stephenson Cancer Center - Oncology ACTIVE_NOT_RECRUITING Oklahoma City Oklahoma 73104 United States Details
Jefferson University Hospitals - Kimmel Cancer Center ACTIVE_NOT_RECRUITING Philadelphia Pennsylvania 17107 United States Details
SCRI oncology partners COMPLETED Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Center - Clinic COMPLETED Dallas Texas 75251 United States Details
The University of Texas - MD Anderson Cancer Center ACTIVE_NOT_RECRUITING Houston Texas 77030 United States Details
Hospital Universitario Clínico San Cecilio RECRUITING Granada Andalusia 18007 Spain Details
Hospital Clínico Universitario de Valladolid RECRUITING Valladolid Castille and León 47003 Spain Details
Hospital de la Santa Creu i Sant Pau RECRUITING Barcelona Catalonia 08025 Spain Details
Hospital San Pedro de Alcántara RECRUITING Cáceres Extremadura 10003 Spain Details
Hospital Universitario 12 de Octubre RECRUITING Madrid Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field